← Eichor
Study identifier: NCT07392736 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Condition: Solid Tumor  ·  Sponsor: Advenchen Laboratories, LLC

PhasePhase 1/Phase 2
Planned participants228
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This trial is an open, non-randomized, phase I/IIa clinical trial, which will evaluate the preliminary effectiveness and safety of AL8326 tablets in patients with advanced solid tumors

This description comes directly from the study's public registry record.

Talk to the study team

Jianbo Wu  ·  13951647454  ·  williamwujianbo@advenchen.com.cn

Always discuss trial participation with your own doctor first.

Locations (15)

National GCP Center for Anticancer Drugs,The Independent Ethics CommitteeBeijing, Beijing Municipality, ChinaRecruiting
The Cancer Hospital of the Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting
Hunan Cancer HospitalHunan, Changsha, ChinaRecruiting
Fujian Cancer HospitalFuzhou, Fujian, ChinaRecruiting
Cancer Hospital of Shantou University Medical CollegeShantou, Guangdong, ChinaRecruiting
Yuebei People's HospitalShaoguan, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Guilin Medical UniverstyGuilin, Guangxi, ChinaRecruiting
Liuzhou Workers' HospitalLiuzhou, Guangxi, ChinaRecruiting
The People's Hospital of Guangxi Zhuang Autonomous RegionNanning, Guangxi, ChinaRecruiting
Guangxi Medical University Cancer HospitalNanning, Guangxi, ChinaRecruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting
The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, Henan, ChinaRecruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07392736